Earnings Call · Q4 FY2024·2025-02-28

Q4 24EPS -27.16%·Rev n/aQ3 24EPS -3.03%·Rev n/aQ2 24EPS -5.26%·Rev n/aQ1 24EPS +9.30%·Rev n/a⚠ consensus missing

RECURSION PHARMACEUTICALS, INC. RXRX

Chris Gibson — Co-Founder and Chief Executive Officer

Lina Nilsson — Chief Operating Officer

Ben Taylor — Chief Financial Officer

−2.1%1d on move date−3.6% vs SPY3d−15.6%5d−18.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RXRX calls or request research access.

More RXRX calls Browse calls Request research access